|
|
|
||
|
|
|||
 |
|||
|
Media Center There is much confusion about Medicare coverage for patients with primary immune deficiency diseases. While IDF is still researching the new program and monitoring the implementation, we want to inform the community that IGIV is not covered under Part D for primary immune deficiency diseases. The Medicare Modernization Act included a special provision under Medicare Part B that covers IGIV for primary immune deficiency diseases in the home care setting. Therefore, if a patient is covered by Medicare, selecting the option of Part B is necessary for proper reimbursement of many of the therapies for primary immune deficiency diseases. Additionally, since coverage of these therapies is usually limited to 80%, it is also important that a patient considers selecting a Medigap policy to help defray the cost of the 20% for which the patient is typically responsible. The new Part D coverage that became available in 2006 includes prescription
drugs that were not previously covered under Medicare. Since IGIV is covered
for primary immune deficiency diseases in the home care setting under
Part B, only patients who do not have primary immune deficiency diseases
may be eligible for coverage under Part D. If you are a primary immune
deficiency patient, your IGIV is not covered under Part D. Please be cautious
when speaking with people who tell you otherwise. Contact IDF with any
questions or concerns you may have. |
|
|